Skip to content
+1 (888) 687-4334 | sales@mountainside-medical.com
Year-End Sale is Live Now - Up to 50% off
New users? Get 5% off on your first purchase.
Free US shipping over $100
Year-End Sale is Live Now - Up to 50% off
New users? Get 5% off on your first purchase.
Free US shipping over $100
Login
Click or scroll to zoom
Tap or pinch to zoom
Ferumoxytol Injection Iron Replacement Medication 510 mg Single-Dose Vial 17 mL
Ferumoxytol Injection Iron Replacement Medication 510 mg Single-Dose Vial 17 mL

Ferumoxytol Injection Iron Replacement Medication 510 mg Single-Dose Vial 17 mL (RX)

by Sandoz
Year End Sale 28%
$ 479.95
$ 345.00
SKU 00781-3154-01
*Mountainside Medical does not fill personal prescriptions Medical Professional License Required to Unlock Account

How to Order:

✔ Send an email request to: sales@mountainside-medical.com

You will receive instructions on how to create an account along with Rx Ordering Details.

(Note: Acceptable licenses must have Prescriptive Authority in the license issuing state.)
Ferumoxytol (brand name Feraheme) is an intravenous iron therapy used to treat iron deficiency anemia in adults. It is given as an injection in a healthcare setting, usually administered in two separate doses spaced a few days apart.

Ferumoxytol Injection by Sandoz is a high-potency intravenous iron replacement medication, supplied as a 30 mg/mL solution in a convenient 17 mL single-dose vial. Designed for healthcare professionals, Ferumoxytol provides rapid and effective treatment of iron deficiency anemia (IDA), particularly in adult patients with chronic kidney disease (CKD) or when oral iron therapy is ineffective or not tolerated.

What is Ferumoxytol Used For?

Ferumoxytol Injection is indicated for:

  • Treatment of iron deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD), including those on dialysis and non-dialysis-dependent.
  • Patients who cannot tolerate oral iron supplements or for whom they have proven ineffective.

CDC Guidelines and Recommendations

  • The Centers for Disease Control and Prevention (CDC) recommend intravenous iron supplementation for CKD patients with iron deficiency anemia, particularly when oral iron is insufficient.
  • Intravenous iron therapy, such as ferumoxytol, is endorsed to quickly restore iron stores, improve hemoglobin levels, and reduce symptoms related to anemia (CDC Chronic Kidney Disease Surveillance System).

Dosage & Administration

Standard Adult Dosage:

  • Each vial contains 510 mg of elemental iron (30 mg/mL x 17 mL).
  • Recommended dose: two separate IV injections of 510 mg each, administered over at least 15 minutes, 3 to 8 days apart (total cumulative dosage: 1,020 mg).
  • Dosage and frequency should be determined by the prescribing healthcare provider based on individual patient needs.

Details and Features

  • Content: 30 mg/mL elemental iron, 17 mL per single-use vial.
  • NDC: 00781-3154-01
  • Brand: Sandoz, a trusted pharmaceutical supplier.
  • Formulation: Stable, ready-to-use injectable solution.
  • Administration: Intravenously, under professional medical supervision.

Mechanism of Action

Ferumoxytol consists of a superparamagnetic iron oxide core surrounded by a carbohydrate shell, allowing for controlled release of iron into the body. The released iron is rapidly incorporated into hemoglobin and other essential iron-dependent proteins, quickly correcting iron deficiency and enabling efficient erythropoiesis (red blood cell production).

Directions for Use

  1. Inspect vial for particulate matter or discoloration prior to use.
  2. Do not dilute or mix with other medications.
  3. Administer via IV injection or infusion, as directed by a healthcare professional.
  4. Each dose should be given slowly, over at least 15 minutes, to reduce the risk of adverse reactions.
  5. Monitor patient closely during and after administration for any signs of hypersensitivity.

Important Warnings

  • Hypersensitivity Reactions: Serious, potentially fatal hypersensitivity reactions, including anaphylaxis, have occurred. Patients should be monitored during and for at least 30 minutes after administration.
  • Hypotension: Monitor blood pressure, as a drop in blood pressure can occur following administration.
  • Iron Overload: Evaluate iron parameters before each dose; avoid in patients with evidence of iron overload.
  • Use in Pregnancy: Limited data available; consult physician prior to use if pregnant or breastfeeding.

Potential Side Effects

The most common adverse reactions include:

  • Nausea
  • Dizziness
  • Hypotension (low blood pressure)
  • Diarrhea
  • Headache
  • Flushing
  • Edema

Serious Side Effects:

  • Hypersensitivity reactions such as rash, urticaria, chest pain, or swelling of the face/lips/throat require immediate medical attention.
  • Severe hypotension, which may require cardiovascular support.

Storage

  • Store at controlled room temperature (20° to 25°C or 68° to 77°F).
  • Do not freeze or expose to extreme heat.

Ferumoxytol Injection by Sandoz offers a safe, efficient, and reliable solution for rapid iron repletion in adults with chronic kidney disease or those who cannot tolerate oral iron, helping to restore energy, reduce anemia symptoms, and improve quality of life under proper medical supervision.

For complete prescribing information, always refer to the official product monograph or consult your healthcare provider.

Ferumoxytol Injection Iron Replacement Medication 510 mg Single-Dose Vial 17 mL (RX)
Ferumoxytol Injection Iron Replacement Medication 510 mg Single-Dose Vial 17 mL (RX)
$ 479.95 $ 345.00
🔒 Medical License Required
Ferumoxytol Injection – Frequently Asked Questions (FAQs)
  • What is Ferumoxytol Injection used for?

    Ferumoxytol is an intravenous (IV) iron replacement therapy used to treat iron deficiency anemia (IDA) in adults with chronic kidney disease (CKD) and, in some cases, for other patients unable to tolerate oral iron or for whom oral iron is ineffective.

  • How is Ferumoxytol administered?

    It is given as a slow intravenous infusion or injection by a healthcare professional, usually in a clinic or hospital setting. The recommended dosing is two injections at least 3 to 8 days apart.

  • How quickly does Ferumoxytol work?

    Improvement in hemoglobin levels is often seen within 1 to 4 weeks after completing the treatment course, depending on individual patient response.

  • What are the common side effects of Ferumoxytol?

    Common side effects include dizziness, nausea, headache, swelling, diarrhea, low blood pressure, and reactions at the injection site. Serious but rare side effects include allergic or hypersensitivity reactions.

  • Are there serious risks associated with Ferumoxytol?

    Yes, rare but potentially serious risks include severe allergic reactions (anaphylaxis) and hypotension during or after the injection. The infusion should be done in a setting where emergency care is available.

  • Who should NOT receive Ferumoxytol?

    It should not be used in patients with a known hypersensitivity to ferumoxytol or any of its components, or who have experienced a serious allergic reaction to any IV iron product.

  • Can Ferumoxytol be used in pregnancy or breastfeeding?

    The safety of ferumoxytol during pregnancy or breastfeeding is not fully established. Tell your doctor if you are pregnant, planning to become pregnant, or breastfeeding before receiving this medication.

  • Does Ferumoxytol interfere with MRI scans?

    Yes. Ferumoxytol can affect the quality of MRI images for up to 3 months after administration. Let your healthcare team and radiologist know if you received this drug before having an MRI.

  • How is Ferumoxytol different from other IV iron products?

    Ferumoxytol can be administered relatively quickly and often requires fewer infusions for a full dose compared to other IV iron formulations.

  • What should I do if I experience symptoms like chest pain, rash, or trouble breathing during or after the injection?

    Notify your healthcare provider immediately, as these could be signs of a serious allergic reaction requiring prompt treatment.

  • Do I need to stop any medications before receiving Ferumoxytol?

    Usually, you do not need to stop medications, but always discuss your full medication list—including over-the-counter drugs and supplements—with your provider.

  • Can children receive Ferumoxytol?

    Currently, ferumoxytol is approved for use in adults; its safety and effectiveness in children have not been established.

  • How should Ferumoxytol be stored before use?

    Ferumoxytol vials should be stored at controlled room temperature and protected from light until prepared for injection by a healthcare professional.

  • Do I need any tests before or after receiving Ferumoxytol?

    Yes. Blood tests to check iron levels, hemoglobin, and kidney function are usually required before and after treatment to monitor response and safety.

  • Can Ferumoxytol be administered with other IV medications?

    Ferumoxytol should not be mixed with or infused simultaneously with other medications through the same IV line. A separate line or thorough flushing is recommended.

Search Any Type of Product, Medication, or Alignment